Stock listing

NASDAQ:BLUE Bluebird bio Inc Stock

Follow Bluebird bio Inc into a list and get an email when it puts out news.

Last close · NASDAQ:BLUE

$4.97 USD

Close on May 30, 2025 · No longer trades

Dec 13, 2024 to last close -21.6% · daily closes, Dec 13, 2024 – May 30, 2025
Lowest – highest close
$3.29 – $9.92 USDSince Dec 13, 2024 · lowest May 12, 2025 · highest Jan 6, 2025

Delisted NASDAQ:BLUE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:BLUE
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Bluebird bio Inc on 6ix

Calls
9 calls with a replay · 9 with a transcript · latest Nov 14, 2024
Decks
27 decks · latest Jan 8, 2024

Events

CallWhenStatus
Bluebird bio (BLUE) Q3 2024 Earnings CallThu, Nov 14, 2024 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q2 2024 Earnings CallWed, Aug 14, 2024 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q1 2024 Earnings CallThu, May 09, 2024 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q4 2023 Earnings CallTue, Mar 26, 2024 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q3 2023 Earnings CallTue, Nov 07, 2023 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q2 2023 Earnings CallTue, Aug 08, 2023 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q4 2022 Earnings CallWed, Mar 29, 2023 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q1 2022 Earnings CallTue, Apr 05, 2022 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q2 2021 Earnings CallMon, Aug 09, 2021 · 8:00 AM ETReplay

Open Events

Decks

DeckKindSlidesDate
J.P. Morgan Healthcare Conference 2024Conference23 slidesJan 8, 2024
Corporate Update (December 2023)Corporate update17 slidesDec 11, 2023
Q2 2023 Earnings PresentationEarnings16 slidesAug 8, 2023
Investor Presentation (July 2023)Investor deck27 slidesJul 12, 2023
Investor Presentation (June 2023)Investor deck27 slidesJun 12, 2023
J.P. Morgan Healthcare Conference 2023Conference29 slidesJan 9, 2023
Conference Presentation (January 2021)Conference27 slidesJan 11, 2021
ASH 2019Conference38 slidesDec 10, 2019
EHA Data Review & ZYNTEGLO Approval Webcast (June 2019)Conference38 slidesJun 14, 2019
39th Annual Cowen Healthcare Conference 2019Conference10 slidesMar 12, 2019
All 27 decks
DeckKindSlidesDate
37th Annual J.P. Morgan Healthcare Conference (January 2019)Conference31 slidesJan 9, 2019
Investor Presentation (January 2019)Investor deck74 slidesJan 7, 2019
ASH 2018Conference55 slidesDec 4, 2018
EHA Analyst & Investor Webcast 2018Conference29 slidesJun 15, 2018
ASCO Analyst & Investor Webcast 2018Conference20 slidesJun 4, 2018
36th Annual J.P. Morgan Healthcare Conference (January 2018)Conference22 slidesJan 8, 2018
Investor Presentation (December 2017)Investor deck5 slidesDec 11, 2017
EHA 2017Conference40 slidesJun 23, 2017
Investor Day (June 2017)Investor day35 slidesJun 5, 2017
Investor Presentation (January 2017)Investor deck55 slidesJan 9, 2017
EORTC-NCI-AACR Molecular Targets and Cancer Therapies Symposium 2016Conference22 slidesDec 1, 2016
American Academy of Neurology Annual Meeting 2016Conference22 slidesApr 20, 2016
Investor Presentation (January 2016)Investor deck47 slidesJan 11, 2016
Investor Day (December 2015)Investor day73 slidesDec 7, 2015
EHA 2015Conference22 slidesJun 15, 2015
Investor Presentation (December 2014)Investor deck24 slidesDec 10, 2014
European Hematology Association (EHA) Congress 2014Conference26 slidesJun 16, 2014

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Michael Cloonan
Other companies: Sionna Therapeutics, Inc. (President & CEO, Director · Since at least Feb 6, 2025); Sage Therapeutics Inc (Chief Business Officer · Apr 2, 2018 – Feb 10, 2021 · Past)
Director · Since at least Jun 20, 2024
Nick Leschly
Other companies: 2Seventy Bio Inc (Director · Oct 18, 2021 – May 13, 2025 · Past); Synlogic Inc (Director · Jun 10, 2021 – Jun 22, 2023 · Past)
Director · Since at least Oct 2, 2020
Jeffrey T. Walsh
Other companies: Tenaya Therapeutics, Inc. (Board Member · Since at least Jul 29, 2021)
Chief Strategy Officer · Mar 11, 2019 – Aug 20, 2019 · Past
Joseph Vittiglio
Other companies: PepGen Inc. (Chief Business & Legal Officer · Since at least Dec 8, 2025)
Chief Business & Legal Officer · Since at least May 30, 2025
Kory Wentworth
Other companies: Entrada Therapeutics, Inc. (Chief Financial Officer · Since at least Oct 28, 2021)
Principal Accounting Officer · Dec 18, 2017 – Aug 3, 2020 · Past
O James Sterling
Other companies: Renalytix PLC (Chief Financial Officer · Jul 1, 2023 – Jul 6, 2023 · Past)
Chief Financial Officer · Since at least Jun 10, 2024
Richard Paulson
Other companies: Karyopharm Therapeutics Inc. (President and CEO, Director · Since at least Apr 4, 2025)
Director · Since at least May 30, 2025
William R Sellers
Other companies: 2Seventy Bio Inc (Director · Oct 18, 2021 – Nov 11, 2021 · Past)
Director · Sep 25, 2019 – Nov 11, 2021 · Past
Andrew ObenshainPresident and CEO, Director · Since at least Nov 3, 2023
Douglas MeltonDirector · Jun 6, 2019 – Jun 18, 2020 · Past
All 14 people
PersonSeat
Jessica WhittenChief Accounting Officer · Nov 4, 2021 – Feb 1, 2022 · Past
Mark VachonDirector · Since at least Nov 6, 2024
Najoh Tita-ReidDirector · Since at least Jun 22, 2022
Richard A ColvinChief Medical Officer · Since at least May 30, 2025

Open People

Log in to ask 6ix AI your own questions about Bluebird bio Inc.